Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.

MLA

Duvivier, Claudine, et al. “Initial Therapy with Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens Is More Effective than with Regimens That Spare Them with No Difference in Short-Term Fat Distribution: Hippocampe-ANRS 121 Trial.” The Journal of Antimicrobial Chemotherapy, vol. 62, no. 4, Oct. 2008, pp. 797–808. EBSCOhost, https://doi.org/10.1093/jac/dkn278.

APA

Duvivier, C., Ghosn, J., Assoumou, L., Soulié, C., Peytavin, G., Calvez, V., Génin, M. A., Molina, J.-M., Bouchaud, O., Katlama, C., & Costagliola, D. (2008). Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial. The Journal of Antimicrobial Chemotherapy, 62(4), 797–808. https://doi.org/10.1093/jac/dkn278

Chicago

Duvivier, Claudine, Jade Ghosn, Lambert Assoumou, Cathia Soulié, Gilles Peytavin, Vincent Calvez, Michèle Algarté Génin, et al. 2008. “Initial Therapy with Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens Is More Effective than with Regimens That Spare Them with No Difference in Short-Term Fat Distribution: Hippocampe-ANRS 121 Trial.” The Journal of Antimicrobial Chemotherapy 62 (4): 797–808. doi:10.1093/jac/dkn278.